Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome

Published:2017 Issue:1 Volume:58 Page:88-94
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Ohmura Hirotoshi¹,Fukushima Yoshifumi¹,Mizuno Atsushi²,Niwa Koichiro²,Kobayashi Yohei³,Ebina Toshiaki⁴,Kimura Kazuo⁴,Ishibashi Shun⁵,Daida Hiroyuki¹,

Affiliation:

1. Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine

2. Department of Cardiology, St. Luke’s International Hospital

3. Department of Cardiology, Kokura Memorial Hospital

4. Department of Cardiovascular Center, Yokohama City University Medical Center

5. Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Jichi Medical University

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/58/1/58_16-188/_pdf

Reference41 articles.

1. 1. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill; 2001: 2863-913.

2. 2. Goldstein JL, Dana SE, Brunschede GY, Brown MS. Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor. Proc Nat Acad Sci U S A 1975; 72: 1092-6.

3. 3. Mabuchi H, Nohara A, Noguchi T, et al. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis 2011; 214: 404-7.

4. 4. Nordestgaard BG, Chapman MJ, Humphries SE, et al; European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and under-treated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013; 34: 3478-90a.

5. 5. Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 2012; 97: 3956-64.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease;Circulation Journal;2024-04-25

2. Prognostic impact of Achilles tendon thickness in elderly patients after percutaneous coronary intervention: A 5-year follow-up;Journal of Cardiology;2023-12

3. Incidence of familial hypercholesterolemia in patients with early manifestations of coronary artery disease: data from a Russian multicenter study and meta-analysis;Russian Journal of Cardiology;2023-08-31

4. Achilles Tendon Thickening as a Risk Factor of Cardiovascular Events after Percutaneous Coronary Intervention;Journal of Atherosclerosis and Thrombosis;2023-05-01

5. Association between Achilles Tendon Softness and Atherosclerotic Cardiovascular Disease in Patients with Familial Hypercholesterolemia;Journal of Atherosclerosis and Thrombosis;2022-11-01